References
- Centers for Disease Control and Prevention. Lower extremity amputations among persons with diabetes mellitus: Washington, 1988. MMWR Morb Mortal Wkly Rep 1991;40(43):737–9
- Calhoun JH, Cantrell J, Cobos J, et al. Treatment of diabetic foot infections: Wagner classification, therapy, and outcome. Foot Ankle 1988;9(3):101–6
- Mills JL, Beckett WC, Taylor SM. The diabetic foot: consequences of delayed treatment and referral. South Med J 1991;84(8):970–4
- Tan JS, Friedman NM, Hazelton-Miller C, et al. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation? Clin Infect Dis 1996;23(2):286–91
- Armstrong DG, Lavery LA, Quebedeaux TL, et al. Surgical morbidity and the risk of amputation due to infected puncture wounds in diabetic versus nondiabetic adults. South Med J 1997;90(4):384–9
- Joseph WS. Treatment of lower extremity infections in diabetics. Drugs 1991;42(6):984–96
- Lipsky BA, Pecoraro RE, Larson SA, et al. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990;150(4):790–7
- Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int 1997; 18(11):716–22
- Sapico FL, Witte JL, Canawati HN, et al. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev Infect Dis 1984; 6 Suppl 1:S171–6
- Wheat LJ, Allen SD, Henry M, et al. Diabetic foot infections: bacteriologic analysis. Arch Intern Med 1986;146(10): 1935–40
- Louie TJ, Bartlett JG, Tally FP, et al. Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 1976;85(4):461–3
- Lipsky BA, Baker PD, Landon GC, et al. Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clin Infect Dis 1997;24(4):643–8
- Peterson LR, Lissack LM, Canter K, et al. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med 1989;86(6 Pt 2):801–8
- Grayson ML, Gibbons GW, Habershaw GM, et al. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994;18(5):683–93 [Erratum, Clin Infect Dis 1994;19(4):820]
- Tan JS, Wishnow RM, Talan DA, et al, for the Piperacillin/Tazobactam Skin and Skin Structure Study Group. Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin- tazobactam versus ticarcillin-clavulanate. Antimicrob Agents Chemother 1993;37(8):1580–6
- Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997;25(6): 1318–26
- Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers: diagnosis and monitoring by leukocyte scanning with indium In 111 oxyquinoline. JAMA 1991;266(9): 1246–51
- Grayson ML, Gibbons GW, Balogh K, et al. Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273(9):721–3
- Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med 1989; 149(10):2262–6
- Eckman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients: decision and cost-effectiveness analyses. JAMA 1995;273(9):712–20
- Rissing JP. Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones. Clin Infect Dis 1997;25(6):1327–33